13 Results for "

Relative binding affinity

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "Relative binding affinity" in MCE Product Catalog:

19
19 Cited Publications
Referencia número: HY-100689
No. CAS: 263717-53-9
Pureza:  99.11%
Synonyms: PPT
Target:  

Estrogen Receptor/ERR

Áreas de investigación:  

Cancer

Propyl pyrazole triol (PPT) is a selective estrogen receptor alpha (ERα) agonist. The relative binding affinity of Propyl pyrazole triol for ERα (ERα: 49%) around 410 times higher compared with estrogen receptor beta (ERβ: 0.12%) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-108637A
No. CAS: 1050480-30-2
Pureza:  99.01%
Target:  

MDM-2/p53

Áreas de investigación:  

Cancer

PhiKan 083 hydrochloride is a carbazole derivative, which binds to the surface cavity and stabilizes Y220C (a p53 mutant), with a Kd of 167 μM , and a relative binding affinity (Kd) of 150 μM in Ln229 cells .
loading...
    loading...
Referencia número: HY-120959
No. CAS: 73025-02-2
Pureza:  98.45%
DAUDA (11-(dansylamino) undecanoic acid) is an environment-sensitive fluorescent fatty acid analogue. DAUDA alters its intensities and fluorescent emission spectra on entry into binding proteins. DAUDA is used to determine the relative affinity of natural fatty acids for polymorphs of the Schistosoma mansoni Sm14 fatty acid-binding protein[1].
loading...
    loading...
Referencia número: HY-16023B
No. CAS: 151533-34-5
Synonyms: EM-343; (Rac)-EM-652
Target:  

Estrogen Receptor/ERR

Áreas de investigación:  

Cancer

(Rac)-Acolbifene (EM-343; (Rac)-EM-652) is the racemic form of EM652 (estrogen receptor?antagonist), has anti-estrogenic and estrogenic activities. (Rac)-Acolbifene (EM-343; (Rac)-EM-652) contains a piperidine ring, shows good pharmacological profile,relative binding affinity (RBA)=380 .
loading...
    loading...
Referencia número: HY-Z12208
No. CAS: 1305124-48-4
N1-Phenylsuberamide is an organic amide compound, and its structure can be regarded as a simplified analogue of Vorinostat (HY-10221). N1-Phenylsuberamide exhibits moderate anti-proliferative activity against MDA-MB-231 and MCF-7 cells. N1-Phenylsuberamide does not show significant HDAC inhibitory activity and can only weakly induce the expression of the p21 gene. N1-Phenylsuberamide has extremely low relative binding affinity of estrogen receptor. N1-Phenylsuberamide can be used as a control compound .
loading...
    loading...
Referencia número: HY-103451
No. CAS: 221368-54-3
Pureza:  ≥99.0%
Target:  

Estrogen Receptor/ERR

Áreas de investigación:  

Metabolic Disease

(R,R)-THC is an ERα agonist and an ERβ antagonist, with Kis of 9.0 nM and 3.6 nM for ERα and ERβ, respectively. (R,R)-THC has higher relative binding affinity for ERβ than ERα with the values of 25 and 3.6 .
loading...
    loading...
Referencia número: HY-117953
No. CAS: 155180-53-3
Áreas de investigación:  

Endocrinology

RU 59063 is an N-substituted arylthiohydantoin compound with antiandrogenic activity and high relative binding affinity for the rat androgen receptor. RU 59063 is a nonsteroidal androgen receptor that functions as a radioactive AR radioprobe (Ki: 0.71 nM, rAR) when its trifluoromethyl group is replaced by a similar hydrophobic iodine atom .
loading...
    loading...
Referencia número: HY-103451A
No. CAS: 138090-06-9
Target:  

Estrogen Receptor/ERR

Áreas de investigación:  

Metabolic Disease

rel-(R,R)-THC is the relative configuration of (R,R)-THC (HY-103451). (R,R)-THC is an ERα agonist and an ERβ antagonist, with Kis of 9.0 nM and 3.6 nM for ERα and ERβ, respectively. (R,R)-THC has higher relative binding affinity for ERβ than ERα with the values of 25 and 3.6 .
loading...
    loading...
Referencia número: HY-168759
No. CAS: 3066-12-4
Áreas de investigación:  

Metabolic Disease Cancer

11α-Hydroxytestosterone is a deriviative of Hydrocortisone (HY-N0583), with the relative binding affinity to progesterone receptor of 9% (comparing to R5020 (HY-119384) 100%). 11α-Hydroxytestosterone inhibits the growth and differentiation of human decidual cells in culture .
loading...
    loading...
Referencia número: HY-131543
No. CAS: 105012-15-5
Synonyms: RU 42698
Áreas de investigación:  

Metabolic Disease

22-Hydroxy Mifepristone (RU 42698) is an orally active hydroxylated alcoholic metabolite with antiprogestational and antiglucocorticoidal activities, which contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. The relative binding affinity of 22-Hydroxy Mifepristone to the human glucocorticoid receptor is 48% .
loading...
    loading...
Referencia número: HY-100689R
No. CAS: 263717-53-9
Synonyms: PPT (Standard)
Áreas de investigación:  

Cancer

Propyl pyrazole triol (Standard) is the analytical standard of Propyl pyrazole triol. This product is intended for research and analytical applications. Propyl pyrazole triol (PPT) is a selective estrogen receptor alpha (ERα) agonist. The relative binding affinity of Propyl pyrazole triol for ERα (ERα: 49%) around 410 times higher compared with estrogen receptor beta (ERβ: 0.12%) .
loading...
    loading...
Referencia número: HY-131543S
Synonyms: RU 42698-d6
22-Hydroxy Mifepristone-d6 is the deuterium labeled 22-Hydroxy Mifepristone (HY-131543). 22-Hydroxy Mifepristone (RU 42698) is an orally active hydroxylated alcoholic metabolite with antiprogestational and antiglucocorticoidal activities, which contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. The relative binding affinity of 22-Hydroxy Mifepristone to the human glucocorticoid receptor is 48% .
loading...
    loading...
Referencia número: HY-164474
Target:  

MEK

Áreas de investigación:  

Cancer

DS03090629 is an orally active, ATP-competitive MEK1/2 inhibitor. DS03090629 binds to the ATP-binding pocket of MEK, and this binding is unaffected by phosphorylation status. DS03090629 exhibits high affinity for both MEK and phosphorylated MEK, with Kd values of 0.11 nM and 0.15 nM, respectively. DS03090629 inhibits the MEK1F53L mutant while retaining activity relative to wild-type MEK1. DS03090629 suppresses the MAPK pathway, cell proliferation, and BRAF overexpression-mediated drug resistance in melanoma cells. DS03090629 can be used for research related to melanoma .
loading...
    loading...
  • 1